Insider Transactions in Q4 2020 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2020
|
Steven M Paul Director |
SELL
Open market or private sale
|
Direct |
15,000
-93.75%
|
$2,100,000
$140.0 P/Share
|
|
Dec 18
2020
|
Steven M Paul Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.39%
|
$135,000
$9.3 P/Share
|
|
Dec 07
2020
|
Phillip A Sharp Director |
BUY
Bona fide gift
|
Indirect |
235,633
+46.89%
|
-
|
|
Dec 07
2020
|
Phillip A Sharp Director |
SELL
Bona fide gift
|
Direct |
235,633
-100.0%
|
-
|
|
Nov 25
2020
|
Phillip A Sharp Director |
SELL
Open market or private sale
|
Direct |
30,000
-2.92%
|
$3,750,000
$125.74 P/Share
|
|
Nov 25
2020
|
Phillip A Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+10.15%
|
$270,000
$9.3 P/Share
|
|
Nov 19
2020
|
John Maraganore Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,765
-3.92%
|
$4,345,625
$125.0 P/Share
|
|
Nov 19
2020
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,765
+13.01%
|
$312,885
$9.14 P/Share
|